Archives of Pediatrics & Adolescent Medicine, a monthly professional medical journal published by the American Medical Association, publishes original, peer-reviewed clinical and basic research articles...
TAKE ACTION: As the Indian Supreme Court readies to hear the Novartis case, MSF tells Novartis to STOP its attack on India, the pharmacy of the developing world. Join MSF & tell Novartis patients matter more than profits
Dodgy science is being smuggled into medical journals thanks to a loophole in the regulations, say Italian psychiatrists Barbui and Cipriani in an important article.
They focus on agomelatine, a recently-approved antidepressant. But their point applies to all of medicine, not just psychiatry.
Here's the problem. Nowadays, major medical journals have rules governing systematic reviews and meta-analyses of clinical trial data. If you want to review the evidence about how well a certain drug works, or its safety, you've got to do it properly. You have to consider all of the data, not just focus on the results that suit you. And so on.
However, these rules don't apply to "narrative" review papers, which is a broad term meaning any kind of article meant to give a discussion of the pharmacology, history, chemistry etc. behind a particular drug. For a narrative review, there are no rules.
Dramatic and unprecedented plumes of methane – a greenhouse gas 20 times more potent than carbon dioxide – have been seen bubbling to the surface of the Arctic Ocean by scientists undertaking an extensive survey of the region.